Johnson & Johnson subsidiary Cordis Endovascular has launched its third-generation drug-eluting stent, the Cypher Select Plus, in many markets throughout the world, including countries in Western and Eastern Europe, Asia Pacific, and the Middle East.
The company expects to offer the device in most markets outside the U.S. and Japan within the next two quarters, according to Warren, NJ-based Cordis.
By AuntMinnie.com staff writers
September 26, 2006
Related Reading
Cordis inks Brivant distribution deal, September 21, 2006
Cordis gets CE Mark for Cypher Select, September 6, 2006
Cordis introduces Steer-It guidewire, August 29, 2006
Cordis builds Irish facility, July 25, 2006
Cordis acquires Ensure Medical, July 13, 2006
Copyright © 2006 AuntMinnie.com
